Medscape

FDA Approves HIV-1 Treatment Ibalizumab for 30-Second IV Push

The Food and Drug Administration (FDA) has approved the HIV-1 medication ibalizumab-uiyk (Trogarzo, Theratechnologies Inc) for administration by intravenous push. Ibalizumab-uiyk, a long-acting ...
Monthly Prescribing Reference

Trogarzo Label Updated With 90-Second IV Push Loading Dose

The new approval allows for the 2000mg loading dose to be administered as an IV push rather than a 30-minute IV infusion. The prescribing information for Trogarzo ® (ibalizumab-uiyk) has been updated ...
Business Wire

Vizient Shares Conservation Strategies for Potential IV Fluid Supply Disruption Caused by Hurricane Helene

IRVING, Texas--(BUSINESS WIRE)--Due to the impact to the Baxter International, Inc. North Cove facility in Marion, N.C. from Hurricane Helene, Vizient has published a conservation guide for adult and ...
Business Insider

Heron Announces FDA Approval of Supplemental New Drug Application to Expand CINVANTI® Label for IV Push

SAN DIEGO, Feb. 26, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class ...
KTLA

Theratechnologies’ Trogarzo® Approved by FDA for 30-Second Intravenous (IV) Push, Simplifying HIV Treatment for Heavily Treatment-Experienced Population

Safety profile of Trogarzo ® IV push similar to that of IV infusion New method of administration designed to make maintenance dosing easier for patients and health care providers and allow more ...
clinicaladvisor.com

Nationwide IV Fluid Shortage Could Change How Hospitals Manage Patient Hydration

Hospital administrators say the shortage accelerated their plans to change IV fluid hydration protocols altogether. KFF Health News — Hospitals around the country are conserving critical intravenous ...